{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T20:58:27Z","timestamp":1791233907585,"version":"4.1.0"},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinica Chimica Acta"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1016\/j.cca.2025.120248","type":"journal-article","created":{"date-parts":[[2025,3,18]],"date-time":"2025-03-18T12:31:38Z","timestamp":1742301098000},"page":"120248","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"special_numbering":"C","title":["The value of serum glial fibrillary acidic protein as a biomarker of astrogliosis in different neurological diseases"],"prefix":"10.1016","volume":"572","author":[{"given":"Luisa","family":"Agnello","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caterina Maria","family":"Gambino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna Maria","family":"Ciaccio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Salemi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Filippo","family":"Brighina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Ragonese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tommaso","family":"Piccoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valeria","family":"Blandino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincenzo","family":"Di Stefano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Cacciabaudo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Masucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberta","family":"Vassallo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Concetta","family":"Scazzone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabio","family":"Del Ben","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6120-9041","authenticated-orcid":false,"given":"Marcello","family":"Ciaccio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cca.2025.120248_b0005","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.ceb.2015.02.004","article-title":"Glial fibrillary acidic protein (GFAP) and the astrocyte intermediate filament system in diseases of the central nervous system","volume":"32","author":"Hol","year":"2015","journal-title":"Curr. Opin. Cell Biol."},{"key":"10.1016\/j.cca.2025.120248_b0010","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1038\/s41583-022-00641-1","article-title":"Astrocyte contribution to dysfunction, risk and progression in neurodegenerative disorders","volume":"24","author":"Brandebura","year":"2023","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.cca.2025.120248_b0015","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1038\/s41392-023-01628-9","article-title":"Astrocytes in human central nervous system diseases: a frontier for new therapies","volume":"8","author":"Verkhratsky","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.cca.2025.120248_b0020","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1038\/s41593-020-00783-4","article-title":"Reactive astrocyte nomenclature, definitions, and future directions","volume":"24","author":"Escartin","year":"2021","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.cca.2025.120248_b0025","doi-asserted-by":"crossref","DOI":"10.1093\/braincomms\/fcae396","article-title":"Glial fibrillary acidic protein in Alzheimer's disease: a narrative review","volume":"6","author":"Leipp","year":"2024","journal-title":"Brain Commun."},{"key":"10.1016\/j.cca.2025.120248_b0030","doi-asserted-by":"crossref","DOI":"10.1177\/1759091420949680","article-title":"GFAP at 50","volume":"12","author":"Messing","year":"2020","journal-title":"ASN Neuro"},{"key":"10.1016\/j.cca.2025.120248_b0035","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1002\/ijc.33724","article-title":"Serum glial fibrillary acidic protein is a predictor of brain metastases in patients with metastatic breast cancer","volume":"149","author":"Darlix","year":"2021","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.cca.2025.120248_b0040","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1186\/s12916-024-03475-z","article-title":"Circulating small extracellular vesicles in Alzheimer\u2019s disease: A case\u2013control study of neuro-inflammation and synaptic dysfunction","volume":"22","author":"Singh","year":"2024","journal-title":"BMC Med."},{"key":"10.1016\/j.cca.2025.120248_b0045","doi-asserted-by":"crossref","first-page":"4323","DOI":"10.3390\/ijms25084323","article-title":"Molecular Biomarkers of Neurodegenerative Disorders: A Practical Guide to Their Appropriate Use and Interpretation in Clinical Practice","volume":"25","author":"Agnello","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.cca.2025.120248_b0050","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.jalz.2011.03.008","article-title":"The Diagnosis of Mild Cognitive Impairment Due to Alzheimer\u2019s Disease: Recommendations from the National Institute on Aging-Alzheimer\u2019s Association Workgroups on Diagnostic Guidelines for Alzheimer\u2019s Disease","volume":"7","author":"Albert","year":"2011","journal-title":"Alzheimer\u2019s Dement."},{"key":"10.1016\/j.cca.2025.120248_b0055","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.jalz.2011.03.005","article-title":"The Diagnosis of Dementia Due to Alzheimer\u2019s Disease: Recommendations from the National Institute on Aging-Alzheimer\u2019s Association Workgroups on Diagnostic Guidelines for Alzheimer\u2019s Disease","volume":"7","author":"McKhann","year":"2011","journal-title":"Alzheimer\u2019s Dement."},{"key":"10.1016\/j.cca.2025.120248_b0060","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.jalz.2018.02.018","article-title":"NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease","volume":"14","author":"Jack","year":"2018","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.cca.2025.120248_b0065","doi-asserted-by":"crossref","first-page":"410","DOI":"10.4103\/psychiatry.IndianJPsychiatry_398_17","article-title":"5-HTTLPR and MTHFR 677C> T polymorphisms and response to yoga-based lifestyle intervention in major depressive disorder: A randomized active-controlled trial","volume":"60","author":"Tolahunase","year":"2018","journal-title":"Indian J. Psychiatry"},{"key":"10.1016\/j.cca.2025.120248_b0070","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1002\/mus.28026","article-title":"Diagnosis and treatment of hereditary transthyretin amyloidosis with polyneuropathy in the United States: Recommendations from a panel of experts","volume":"69","author":"Karam","year":"2024","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.cca.2025.120248_b0075","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1007\/s00415-019-09688-0","article-title":"Expert consensus recommendations to improve diagnosis of ATTR amyloidosis with polyneuropathy","volume":"268","author":"Adams","year":"2021","journal-title":"J. Neurol."},{"key":"10.1016\/j.cca.2025.120248_b0080","first-page":"1","article-title":"MatchIt: Nonparametric Preprocessing for Parametric Causal Inference","volume":"42","author":"Stuart","year":"2011","journal-title":"J. Stat. Softw."},{"key":"10.1016\/j.cca.2025.120248_b0085","doi-asserted-by":"crossref","first-page":"3167","DOI":"10.21105\/joss.03167","article-title":"Visualizations with statistical details: The 'ggstatsplot' approach","volume":"6","author":"Patil","year":"2021","journal-title":"J. Open Source Softw."},{"key":"10.1016\/j.cca.2025.120248_b0090","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1038\/s41582-023-00822-1","article-title":"Functional roles of reactive astrocytes in neuroinflammation and neurodegeneration","volume":"19","author":"Patani","year":"2023","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.cca.2025.120248_b0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2021.101335","article-title":"Reactive astrocytes: The nexus of pathological and clinical hallmarks of Alzheimer's disease","volume":"68","author":"Price","year":"2021","journal-title":"Ageing Res. Rev."},{"key":"10.1016\/j.cca.2025.120248_b0100","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1007\/s10072-023-07065-4","article-title":"The role of plasma neurofilament light chain and glial fibrillary acidic protein in subjective cognitive decline and mild cognitive impairment","volume":"45","author":"Mazzeo","year":"2024","journal-title":"Neurol. Sci."},{"key":"10.1016\/j.cca.2025.120248_b0105","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.3390\/cells12091309","article-title":"GFAP as a potential biomarker for Alzheimer's disease: A systematic review and meta-analysis","volume":"12","author":"Kim","year":"2023","journal-title":"Cells"},{"key":"10.1016\/j.cca.2025.120248_b0110","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2022.887498","article-title":"Real-world applicability of glial fibrillary acidic protein and neurofilament light chain in Alzheimer's disease","volume":"14","author":"Parvizi","year":"2022","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.cca.2025.120248_b0115","doi-asserted-by":"crossref","first-page":"e87","DOI":"10.1016\/S2666-7568(20)30061-1","article-title":"Serum markers glial fibrillary acidic protein and neurofilament light for prognosis and monitoring in cognitively normal older people: A prospective memory clinic-based cohort study","volume":"2","author":"Verberk","year":"2021","journal-title":"Lancet Healthy Longev."},{"key":"10.1016\/j.cca.2025.120248_b0120","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.jalz.2018.02.018","article-title":"NIA-AA Research Framework: Toward a biological definition of Alzheimer\u2019s disease","volume":"14","author":"Jack","year":"2018","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.cca.2025.120248_b0125","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1093\/brain\/awae035","article-title":"Serum GFAP levels correlate with astrocyte reactivity, post-mortem brain atrophy and neurofibrillary tangles","author":"S\u00e1nchez-Juan","year":"2024","journal-title":"Brain 147"},{"key":"10.1016\/j.cca.2025.120248_b0130","doi-asserted-by":"crossref","first-page":"4594","DOI":"10.3390\/ijms25094594","article-title":"Assessment of the correlation and diagnostic accuracy between cerebrospinal fluid and plasma Alzheimer's disease biomarkers: A comparison of the Lumipulse and Simoa platforms","volume":"25","author":"Dakterzada","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.cca.2025.120248_b0135","doi-asserted-by":"crossref","first-page":"2520","DOI":"10.3390\/diagnostics14222520","article-title":"Glial Fibrillary Acidic Protein's Usefulness as an Astrocyte Biomarker Using the Fully Automated LUMIPULSE\u00ae System","volume":"14","author":"Kamada","year":"2024","journal-title":"Diagnostics"},{"key":"10.1016\/j.cca.2025.120248_b0140","doi-asserted-by":"crossref","first-page":"16084","DOI":"10.1038\/s41598-024-66923-z","article-title":"Evaluation of core biomarkers of Alzheimer's disease in saliva and plasma measured by chemiluminescent enzyme immunoassays on a fully automated platform","volume":"14","author":"Agnello","year":"2024","journal-title":"Sci. Rep."},{"key":"10.1016\/j.cca.2025.120248_b0145","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1093\/jalm\/jfae099","article-title":"Comparison of a fully automated platform and an established ELISA for the quantification of neurofilament light chain in patients with cognitive decline","volume":"9","author":"Agnello","year":"2024","journal-title":"J. Appl. Lab. Med."},{"key":"10.1016\/j.cca.2025.120248_b0150","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/s13195-024-01397-9","article-title":"Exploring the potential of fully automated LUMIPULSE G plasma assays for detecting Alzheimer's disease pathology","volume":"16","author":"Silva-Sp\u00ednola","year":"2024","journal-title":"Alzheimers Res. Ther."},{"key":"10.1016\/j.cca.2025.120248_b0155","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuint.2024.105837","article-title":"Transthyretin Amyloidosis: Role of oxidative stress and the beneficial implications of antioxidants and nutraceutical supplementation","volume":"179","author":"Eze","year":"2024","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.cca.2025.120248_b0160","doi-asserted-by":"crossref","first-page":"106625","DOI":"10.18632\/oncotarget.22542","article-title":"Neuron-derived transthyretin modulates astrocytic glycolysis in a hormone-independent manner","volume":"8","author":"Zawi\u015blak","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.cca.2025.120248_b0165","first-page":"6105","article-title":"The role of transthyretin in cell biology: Impact on human pathophysiology, Cell Mol","volume":"78","author":"Magalh\u00e3es","year":"2021","journal-title":"Life Sci."},{"key":"10.1016\/j.cca.2025.120248_b0170","doi-asserted-by":"crossref","first-page":"14798","DOI":"10.1038\/s41598-018-33158-8","article-title":"Serum GFAP as a biomarker for disease severity in multiple sclerosis","volume":"8","author":"Abdelhak","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.cca.2025.120248_b0175","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1177\/1352458518819380","article-title":"Serum glial fibrillary acidic protein correlates with multiple sclerosis disease severity","volume":"26","author":"H\u00f6gel","year":"2020","journal-title":"Mult. Scler."},{"key":"10.1016\/j.cca.2025.120248_b0180","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1007\/s00415-010-5863-2","article-title":"Glial fibrillary acidic protein: A potential biomarker for progression in multiple sclerosis","volume":"258","author":"Axelsson","year":"2011","journal-title":"J. Neurol."}],"container-title":["Clinica Chimica Acta"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898125001275?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898125001275?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,8,5]],"date-time":"2025-08-05T15:28:03Z","timestamp":1754407683000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009898125001275"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":36,"alternative-id":["S0009898125001275"],"URL":"https:\/\/doi.org\/10.1016\/j.cca.2025.120248","relation":{},"ISSN":["0009-8981"],"issn-type":[{"value":"0009-8981","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The value of serum glial fibrillary acidic protein as a biomarker of astrogliosis in different neurological diseases","name":"articletitle","label":"Article Title"},{"value":"Clinica Chimica Acta","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cca.2025.120248","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"120248"}}